DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Cicenas S, Geater SL, Petrov P. et al.
Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study).
Lung Cancer 2016;
102: 30-37
We do not assume any responsibility for the contents of the web pages of other providers.